In addition, Kim et al. presented that any metastasizing malignant cell derived from EpCAM loss in CRC might present loss or decreased expression of EpCAM, and in these cases, CTCs cannot be detected despite being present [43]. This evidence concerns the gene EPCAM and colorectal carcinoma.